Amine Abdelaziz

Amine ABDELAZIZ has extensive experience in the pharmaceutical and healthcare sectors, currently serving as the Business Unit Director for Haemophilia, BI & Digital France at Sobi - Swedish Orphan Biovitrum AB since May 2017, while also holding roles as Regional Director for North Africa & Türkiye and Business Unit Director for North Africa. Prior to Sobi, Amine ABDELAZIZ worked at Novo Nordisk as a Medical Advisor for Haemophilia and related therapies from December 2013 to April 2017. Additional roles include Sales Specialist at GE Healthcare and Oral Surgeon in private practice. Amine ABDELAZIZ began a career in the pharmaceutical industry with The Janssen Pharmaceutical Companies of Johnson & Johnson as a Medical Science Liaison and Medical Representative. Academic qualifications include an Executive MBA from HEC Paris (2024-2025) and a Diplome d'Etudes Médicales Spécialisées in Oral Surgery from the Faculté de Médecine, Université d'Alger (2000-2009).